Scientists at UC San Francisco put AI to work analyzing study participants’ gaits, then had it develop personalized brain ...

A new study led by Bucknell University Professor Karlo Malaga, biomedical engineering, has identified key insights into optimizing deep brain stimulation (DBS) for Parkinson's disease patients.

In Cleveland’s humid summer heat, Michal Gostkowski, DO, doesn’t need a jacket. In fall, perhaps a light coat. As winter’s cold bite creeps in, he’ll be sure to bundle up. Just like changing outerwear ...

The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...

Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...

For years, researchers have watched the tiny power plants inside brain cells falter in Parkinson’s disease and wondered what ...

Cleveland researchers used innovative balloon game to motivate participants through cycling sessions that showed measurable changes in neural connections.

The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for people with Parkinson’s disease, offering a deep-brain stimulation approach to ...

The beneficial effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on pain in patients with Parkinson's disease (PD) persist long term, a new study has found. The study showed that all ...

For decades, scientists have known that mitochondria, which produce energy inside our cells, malfunction in Parkinson's disease. But a critical question remained: do the failing mitochondria cause ...